Lumosa Therapeutics Co., Ltd. (TPEX:6535)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
174.00
+1.00 (0.58%)
Apr 2, 2025, 10:45 AM CST

Lumosa Therapeutics Revenue

In the year 2024, Lumosa Therapeutics had annual revenue of 39.15M TWD, down -31.21%. Lumosa Therapeutics had revenue of 19.81M in the quarter ending December 31, 2024, with 7.25% growth.

Revenue
39.15M
Revenue Growth
-31.21%
P/S Ratio
n/a
Revenue / Employee
910.56K
Employees
43
Market Cap
29.22B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202439.15M-17.76M-31.21%
Dec 31, 202356.92M30.27M113.63%
Dec 31, 202226.64M9.28M53.45%
Dec 31, 202117.36M-4.29M-19.81%
Dec 31, 202021.65M-150.39M-87.42%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition